enGene (ENGNW) Competitors $0.59 -0.01 (-1.73%) As of 04/1/2025 02:52 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock ENGNW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CALAShould you be buying enGene stock or one of its competitors? The main competitors of enGene include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Calithera Biosciences (CALA). These companies are all part of the "pharmaceutical products" industry. enGene vs. 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Ainos Alvotech Atlantic Coastal Acquisition Corp. II Biofrontera biote BriaCell Therapeutics Calithera Biosciences enGene (NASDAQ:ENGNW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their media sentiment, valuation, analyst recommendations, profitability, earnings, dividends, risk, institutional ownership and community ranking. Which has stronger valuation & earnings, ENGNW or ATNFW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioenGeneN/AN/AN/AN/AN/A180 Life SciencesN/AN/AN/AN/AN/A Is ENGNW or ATNFW more profitable? Company Net Margins Return on Equity Return on Assets enGeneN/A N/A N/A 180 Life Sciences N/A N/A N/A Does the MarketBeat Community believe in ENGNW or ATNFW? enGene and 180 Life Sciences both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformenGeneN/AN/A180 Life SciencesN/AN/A Does the media favor ENGNW or ATNFW? In the previous week, enGene had 2 more articles in the media than 180 Life Sciences. MarketBeat recorded 2 mentions for enGene and 0 mentions for 180 Life Sciences. 180 Life Sciences' average media sentiment score of 1.89 beat enGene's score of 0.99 indicating that 180 Life Sciences is being referred to more favorably in the news media. Company Overall Sentiment enGene Positive 180 Life Sciences Very Positive SummaryenGene and 180 Life Sciences tied by winning 1 of the 2 factors compared between the two stocks. Remove Ads Get enGene News Delivered to You Automatically Sign up to receive the latest news and ratings for ENGNW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ENGNW vs. The Competition Export to ExcelMetricenGeneBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$115.16M$5.54B$7.86BDividend YieldN/A3.69%5.35%4.06%P/E RatioN/A3.1523.4418.67Price / SalesN/A4,117.48367.8787.31Price / CashN/A13.0138.1634.64Price / BookN/A35.606.634.09Net IncomeN/A-$87.82M$3.20B$246.93M7 Day Performance-3.28%-4.37%-5.00%-3.16%1 Month Performance-18.06%57.62%-1.57%-6.74%1 Year Performance-88.41%86.75%8.72%-0.49% enGene Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ENGNWenGeneN/A$0.59-1.7%N/A-88.4%$0.00N/A0.0031News CoverageATNFW180 Life SciencesN/A$0.01-12.5%N/A-14.6%$0.00N/A0.007Positive NewsGap DownHigh Trading VolumeLBPSW4D pharmaN/AN/AN/AN/A$0.00$522,000.000.00N/AAEHAWAesther Healthcare AcquisitionN/A$0.03+16.1%N/A-83.3%$0.00N/A0.002Gap UpAIMDWAinosN/A$0.11-8.3%N/A+57.1%$0.00$20,729.000.0040Positive NewsALVOWAlvotechN/A$1.40-7.3%N/A-57.6%$0.00$489.68M0.004Short Interest ↓Positive NewsGap DownACABWAtlantic Coastal Acquisition Corp. IIN/A$0.03flatN/AN/A$0.00N/A0.0015BFRIWBiofronteraN/A$0.06-36.2%N/A-7.7%$0.00$37.32M0.0070Positive NewsGap DownBTMDWbioteN/A$0.06-2.4%N/A-88.4%$0.00$197.19M0.00N/ABCTXWBriaCell TherapeuticsN/A$0.09-10.9%N/A-92.6%$0.00N/A0.008Positive NewsGap DownCALACalithera BiosciencesN/A$0.00-83.3%N/A-99.5%$0.00N/A0.0060Analyst ForecastGap Down Remove Ads Related Companies and Tools Related Companies 180 Life Sciences Alternatives 4D pharma Alternatives Aesther Healthcare Acquisition Alternatives Ainos Alternatives Alvotech Alternatives Atlantic Coastal Acquisition Corp. II Alternatives Biofrontera Alternatives biote Alternatives BriaCell Therapeutics Alternatives Calithera Biosciences Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ENGNW) was last updated on 4/2/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredTrump’s Great Society Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding enGene Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share enGene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
